-
1
-
-
0035512850
-
Nosocomial infections in pediatric intensive care units
-
COI: 1:STN:280:DC%2BD38%2FktFKjsQ%3D%3D, PID: 11770243
-
Lodha R, Natchu UC, Nanda M et al (2001) Nosocomial infections in pediatric intensive care units. Indian J Pediatr 68:1063–1070
-
(2001)
Indian J Pediatr
, vol.68
, pp. 1063-1070
-
-
Lodha, R.1
Natchu, U.C.2
Nanda, M.3
-
2
-
-
0031967825
-
Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients
-
COI: 1:STN:280:DyaK1c3itlahsA%3D%3D, PID: 9563733
-
Girou E, Stephan F, Novara A et al (1998) Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 157:1151–1158. doi:10.1164/ajrccm.157.4.9701129
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 1151-1158
-
-
Girou, E.1
Stephan, F.2
Novara, A.3
-
3
-
-
50649088378
-
Ventilator-associated pneumonia in adults in developing countries: a systematic review
-
PID: 18502674
-
Arabi Y, Al-Shirawi N, Memish Z, Anzueto A (2008) Ventilator-associated pneumonia in adults in developing countries: a systematic review. Int J Infect Dis 12:505–512. doi:10.1016/j.ijid.2008.02.010
-
(2008)
Int J Infect Dis
, vol.12
, pp. 505-512
-
-
Arabi, Y.1
Al-Shirawi, N.2
Memish, Z.3
Anzueto, A.4
-
4
-
-
0025804332
-
Probiotics in human medicine
-
COI: 1:STN:280:DyaK3M3isVGhsg%3D%3D, PID: 1902810
-
Fuller R (1991) Probiotics in human medicine. Gut 32:439–442
-
(1991)
Gut
, vol.32
, pp. 439-442
-
-
Fuller, R.1
-
5
-
-
79955557228
-
Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions
-
COI: 1:CAS:528:DC%2BC3MXmt1ynsbw%3D, PID: 21233408
-
Gourbeyre P, Denery S, Bodinier M (2011) Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol 89:685–695. doi:10.1189/jlb.1109753
-
(2011)
J Leukoc Biol
, vol.89
, pp. 685-695
-
-
Gourbeyre, P.1
Denery, S.2
Bodinier, M.3
-
6
-
-
77955919598
-
Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial
-
PID: 20502866
-
Barraud D, Blard C, Hein F et al (2010) Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med 36:1540–1547. doi:10.1007/s00134-010-1927-0
-
(2010)
Intensive Care Med
, vol.36
, pp. 1540-1547
-
-
Barraud, D.1
Blard, C.2
Hein, F.3
-
7
-
-
77958006512
-
Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial
-
PID: 20522788
-
Morrow LE, Kollef MH, Casale TB (2010) Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 182:1058–1064. doi:10.1164/rccm.200912-1853OC
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 1058-1064
-
-
Morrow, L.E.1
Kollef, M.H.2
Casale, T.B.3
-
8
-
-
84893189792
-
Probiotics for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of high-quality randomized controlled trials
-
PID: 24367620
-
Wang J, Liu K, Ariani F et al (2013) Probiotics for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of high-quality randomized controlled trials. PLoS One 8:e83934. doi:10.1371/journal.pone.0083934
-
(2013)
PLoS One
, vol.8
, pp. e83934
-
-
Wang, J.1
Liu, K.2
Ariani, F.3
-
9
-
-
84932632329
-
Probiotics for preventing ventilator-associated pneumonia
-
PID: 25344083
-
Bo L, Li J, Tao T et al (2014) Probiotics for preventing ventilator-associated pneumonia. Cochrane Database Syst Rev 10:CD009066. doi:10.1002/14651858.CD009066.pub2
-
(2014)
Cochrane Database Syst Rev
, vol.10
, pp. CD009066
-
-
Bo, L.1
Li, J.2
Tao, T.3
-
10
-
-
77249176572
-
Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials
-
PID: 20016381
-
Siempos II, Ntaidou TK, Falagas ME (2010) Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 38:954–962. doi:10.1097/CCM.0b013e3181c8fe4b
-
(2010)
Crit Care Med
, vol.38
, pp. 954-962
-
-
Siempos, I.I.1
Ntaidou, T.K.2
Falagas, M.E.3
-
12
-
-
84860863711
-
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
-
Johnston BC, Goldenberg JZ, Vandvik PO et al (2011) Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 9:CD004827. doi:10.1002/14651858.CD004827.pub3
-
(2011)
Cochrane Database Syst Rev
, vol.9
, pp. CD004827
-
-
Johnston, B.C.1
Goldenberg, J.Z.2
Vandvik, P.O.3
-
13
-
-
84927509691
-
Cochrane in context: probiotics for prevention of necrotizing enterocolitis in preterm infants
-
PID: 25236308
-
Robinson J (2014) Cochrane in context: probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid Based Child Health 9:672–674. doi:10.1002/ebch.1977
-
(2014)
Evid Based Child Health
, vol.9
, pp. 672-674
-
-
Robinson, J.1
-
14
-
-
9244228530
-
Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995
-
American Thoracic Society (1996) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med 153:1711–1725. 10.1164/ajrccm.153.5.8630626
-
(1996)
Am J Respir Crit Care Med 153:1711–1725. 10.1164/ajrccm.153
, pp. 5
-
-
-
15
-
-
0032911760
-
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients
-
COI: 1:STN:280:DyaK1M7kvFKqtg%3D%3D, PID: 10027448
-
Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474
-
(1999)
Chest
, vol.115
, pp. 462-474
-
-
Kollef, M.H.1
Sherman, G.2
Ward, S.3
Fraser, V.J.4
-
16
-
-
34548672553
-
Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial
-
PID: 17693918, (quiz 464)
-
Honeycutt TCB, El Khashab M, Wardrop RM 3rd et al (2007) Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr Crit Care Med 8:452–458. doi:10.1097/01.PCC.0000282176.41134.E6 (quiz 464)
-
(2007)
Pediatr Crit Care Med
, vol.8
, pp. 452-458
-
-
Honeycutt, T.C.B.1
El Khashab, M.2
Wardrop, R.M.3
-
17
-
-
79961097580
-
Microaspiration in intubated critically ill patients: diagnosis and prevention
-
COI: 1:CAS:528:DC%2BC3MXhtVSmsL3J, PID: 21679139
-
Nseir S, Zerimech F, Jaillette E et al (2011) Microaspiration in intubated critically ill patients: diagnosis and prevention. Infect Disord Drug Targets 11:413–423
-
(2011)
Infect Disord Drug Targets
, vol.11
, pp. 413-423
-
-
Nseir, S.1
Zerimech, F.2
Jaillette, E.3
-
18
-
-
27244457431
-
The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention
-
PID: 15913465, (discussion 739–741)
-
Safdar N, Crnich CJ, Maki DG (2005) The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 50:725–739 (discussion 739–741)
-
(2005)
Respir Care
, vol.50
, pp. 725-739
-
-
Safdar, N.1
Crnich, C.J.2
Maki, D.G.3
-
19
-
-
0032816821
-
Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity
-
COI: 1:STN:280:DyaK1Mzjt1alsg%3D%3D, PID: 10403734
-
MacFie J, O’Boyle C, Mitchell CJ et al (1999) Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 45:223–228
-
(1999)
Gut
, vol.45
, pp. 223-228
-
-
MacFie, J.1
O’Boyle, C.2
Mitchell, C.J.3
-
20
-
-
16444367569
-
Current status of bacterial translocation as a cause of surgical sepsis
-
PID: 15596865
-
MacFie J (2004) Current status of bacterial translocation as a cause of surgical sepsis. Br Med Bull 71:1–11. doi:10.1093/bmb/ldh029
-
(2004)
Br Med Bull
, vol.71
, pp. 1-11
-
-
MacFie, J.1
-
22
-
-
0037304556
-
Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci)
-
PID: 12540416
-
Glück U, Gebbers J-O (2003) Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 77:517–520
-
(2003)
Am J Clin Nutr
, vol.77
, pp. 517-520
-
-
Glück, U.1
Gebbers, J.-O.2
-
23
-
-
44849142149
-
Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients
-
Forestier C, Guelon D, Cluytens V et al (2008) Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care Lond Engl 12:R69. doi:10.1186/cc6907
-
(2008)
Crit Care Lond Engl
, vol.12
, pp. R69
-
-
Forestier, C.1
Guelon, D.2
Cluytens, V.3
-
24
-
-
84864350982
-
In vitro evaluation of single- and multi-strain probiotics: inter-species inhibition between probiotic strains, and inhibition of pathogens
-
COI: 1:STN:280:DC%2BC38npvVyqsg%3D%3D, PID: 22677262
-
Chapman CMC, Gibson GR, Rowland I (2012) In vitro evaluation of single- and multi-strain probiotics: inter-species inhibition between probiotic strains, and inhibition of pathogens. Anaerobe 18:405–413. doi:10.1016/j.anaerobe.2012.05.004
-
(2012)
Anaerobe
, vol.18
, pp. 405-413
-
-
Chapman, C.M.C.1
Gibson, G.R.2
Rowland, I.3
-
25
-
-
79961201198
-
Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre- and probiotics in critically ill children
-
COI: 1:CAS:528:DC%2BC3MXptlyrtro%3D, PID: 21788759
-
Simakachorn N, Bibiloni R, Yimyaem P et al (2011) Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre- and probiotics in critically ill children. J Pediatr Gastroenterol Nutr 53:174–181. doi:10.1097/MPG.0b013e318216f1ec
-
(2011)
J Pediatr Gastroenterol Nutr
, vol.53
, pp. 174-181
-
-
Simakachorn, N.1
Bibiloni, R.2
Yimyaem, P.3
-
26
-
-
33646102897
-
Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children
-
PID: 16456410
-
Srinivasan R, Meyer R, Padmanabhan R, Britto J (2006) Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children. J Pediatr Gastroenterol Nutr 42:171–173. doi:10.1097/01.mpg.0000189335.62397.cf
-
(2006)
J Pediatr Gastroenterol Nutr
, vol.42
, pp. 171-173
-
-
Srinivasan, R.1
Meyer, R.2
Padmanabhan, R.3
Britto, J.4
-
27
-
-
66849084285
-
Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial
-
PID: 19369375
-
Rougé C, Piloquet H, Butel M-J et al (2009) Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 89:1828–1835. doi:10.3945/ajcn.2008.26919
-
(2009)
Am J Clin Nutr
, vol.89
, pp. 1828-1835
-
-
Rougé, C.1
Piloquet, H.2
Butel, M.-J.3
-
28
-
-
63849262971
-
Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns
-
PID: 18842610
-
Samanta M, Sarkar M, Ghosh P et al (2009) Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 55:128–131. doi:10.1093/tropej/fmn091
-
(2009)
J Trop Pediatr
, vol.55
, pp. 128-131
-
-
Samanta, M.1
Sarkar, M.2
Ghosh, P.3
-
29
-
-
54049148570
-
Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial
-
PID: 18829790
-
Lin H-C, Hsu C-H, Chen H-L et al (2008) Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122:693–700. doi:10.1542/peds.2007-3007
-
(2008)
Pediatrics
, vol.122
, pp. 693-700
-
-
Lin, H.-C.1
Hsu, C.-H.2
Chen, H.-L.3
-
30
-
-
33745628389
-
Probiotic use in clinical practice: what are the risks?
-
COI: 1:CAS:528:DC%2BD28XlvFCmtLo%3D, PID: 16762934, (quiz 1446–1447)
-
Boyle RJ, Robins-Browne RM, Tang MLK (2006) Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83:1256–1264 (quiz 1446–1447)
-
(2006)
Am J Clin Nutr
, vol.83
, pp. 1256-1264
-
-
Boyle, R.J.1
Robins-Browne, R.M.2
Tang, M.L.K.3
-
31
-
-
33750934421
-
Safety of probiotics: comparison of two popular strains
-
PID: 17095783
-
Hammerman C, Bin-Nun A, Kaplan M (2006) Safety of probiotics: comparison of two popular strains. BMJ 333:1006–1008. doi:10.1136/bmj.39010.630799.BE
-
(2006)
BMJ
, vol.333
, pp. 1006-1008
-
-
Hammerman, C.1
Bin-Nun, A.2
Kaplan, M.3
-
32
-
-
33749001956
-
Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: early results of a randomized controlled trial
-
PID: 16983476
-
Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A et al (2006) Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg 30:1848–1855. doi:10.1007/s00268-005-0653-1
-
(2006)
World J Surg
, vol.30
, pp. 1848-1855
-
-
Kotzampassi, K.1
Giamarellos-Bourboulis, E.J.2
Voudouris, A.3
-
33
-
-
84871629984
-
Manipulation of the gut microbiota as a novel treatment strategy for gastrointestinal disorders
-
COI: 1:CAS:528:DC%2BC38XhtVemu7zJ
-
Foxx-Orenstein AE, Chey WD (2012) Manipulation of the gut microbiota as a novel treatment strategy for gastrointestinal disorders. Am J Gastroenterol Suppl 1:41–46. doi:10.1038/ajgsup.2012.8
-
(2012)
Am J Gastroenterol Suppl
, vol.1
, pp. 41-46
-
-
Foxx-Orenstein, A.E.1
Chey, W.D.2
|